Therapeutic blockade of VEGF has been shown to inhibit primary and metastatic tumour growth in animal models (Kim et al, 1993; Asano et al, 1995; Benjamin and Keshet 1997), which has been attributed to an antiangiogenic effect. Here, VEGFA is linked to neoplasm.